NovaBridge Biosciences Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements
NovaBridge Biosciences (NBP) reported Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements of 266.46 thousand shares for the 12-month period ending 2020-12-31, per its 20-F filed 2023-05-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements · last filed 2023-05-01
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 12 month |
|---|---|
| 2020-12-31 | 266.46K shares 20-F · filed 2023-05-01 |